Prednisolone has been suggested as a treatment for olfactory disorders after COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral prednisolone treatment on patients with persistent olfactory disorders after COVID-19. We performed a randomized, double-blind, placebo-controlled, single-centered trial in the Netherlands. Patients were included if they were > 18 years old and if they had persistent (> 4 weeks) olfactory disorders within 12 weeks after a confirmed COVID-19 test. The treatment group received oral prednisolone 40 mg once daily for 10 days and the placebo group received matching placebo. In addition, all patients performed olfactory training. The primary outcome was the objective olfactory function on Sniffin’ Sticks Test (SST) 12 weeks after the start of treatment, measured in Threshold-Discrimination-Identification (TDI) score. Secondary outcomes
Voor ons en natuurlijk dankzij de Here God – De Groene Amsterdammer
groene.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from groene.nl Daily Mail and Mail on Sunday newspapers.
Hier en daar wat vragen, maar GGD tevreden over opkomst in vaccinatiestraat Veenendaal
rtvutrecht.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rtvutrecht.nl Daily Mail and Mail on Sunday newspapers.